Johnson & Johnson (JNJ)

JNJ on New York Consolidated

102.42USD
23 Oct 2014
Price Change (% chg)

$1.20 (+1.19%)
Prev Close
$101.22
Open
$102.26
Day's High
$102.79
Day's Low
$101.94
Volume
2,511,012
Avg. Vol
7,210,099
52-wk High
$108.77
52-wk Low
$86.09

JNJ

Chart for JNJ

About

Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The business of Johnson & Johnson is conducted by more than 275 operating companies located in 60 countries, including the United States, which sell products... (more)

Overall

Beta: 0.59
Market Cap (Mil.): $285,469.50
Shares Outstanding (Mil.): 2,820.29
Dividend: 0.70
Yield (%): 2.77

Financials

  JNJ Industry Sector
P/E (TTM): 16.78 32.88 33.65
EPS (TTM): 6.03 -- --
ROI: -- 18.21 17.48
ROE: -- 18.89 18.31
Search Stocks

J&J, GSK ready to collaborate on Ebola vaccine work

LONDON - Drugmakers will work together to accelerate development of an Ebola vaccine and Johnson & Johnson and GlaxSmithKline, both of which have experimental vaccine candidates, have already discussed collaboration.

22 Oct 2014

J&J, GSK ready to collaborate on Ebola vaccine work

LONDON, Oct 22 - Drugmakers will work together to accelerate development of an Ebola vaccine and Johnson & Johnson and GlaxSmithKline, both of which have experimental vaccine candidates, have already discussed collaboration.

22 Oct 2014

J&J and Bavarian Nordic expand production of an Ebola vaccine program

- Johnson & Johnson said it has made a commitment of up to $200 million to accelerate and significantly expand the production of an Ebola vaccine program.

22 Oct 2014

J&J and Bavarian Nordic expand production of an Ebola vaccine program

Oct 22 - Johnson & Johnson said it has made a commitment of up to $200 million to accelerate and significantly expand the production of an Ebola vaccine program.

22 Oct 2014

Jury deliberations begin in first trial over DePuy's Pinnacle hips

- A lawyer for a Montana woman on Tuesday urged jurors in a U.S. court to find Johnson & Johnson's DePuy Orthopedics unit liable for failing to warn patients that metal-on-metal Pinnacle hip implants were defective at the close of the first trial over the device.

21 Oct 2014

Jury deliberations begin in first trial over DePuy's Pinnacle hips

Oct 21 - A lawyer for a Montana woman on Tuesday urged jurors in a U.S. court to find Johnson & Johnson's DePuy Orthopaedics unit liable for failing to warn patients that metal-on-metal Pinnacle hip implants were defective at the close of the first trial over the device.

21 Oct 2014

RPT-Tens of thousands expected to get Ebola vaccines from January - WHO

GENEVA, Oct 21 - Tens of thousands of people in West Africa are expected to begin getting experimental Ebola vaccines from January, but population-wide immunisation is still far off, the World Health Organization (WHO) said on Tuesday.

21 Oct 2014

Tens of thousands expected to get Ebola vaccines from January - WHO

GENEVA, Oct 21 - Tens of thousands of people in West Africa are expected to begin getting experimental Ebola vaccines from January, but population-wide immunisation is still far off, the World Health Organization (WHO) said on Tuesday.

21 Oct 2014

J&J beats forecasts, helped by hepatitis drug

- Johnson & Johnson reported strong quarterly earnings on surging sales of a new treatment for hepatitis C, but the company said it had sharply reduced prices for its artificial hips and warned that profits could be hurt next year by the stronger dollar.

14 Oct 2014

UPDATE 3-J&J beats forecasts, helped by hepatitis drug

(Adds analyst comment, details on price cuts, stronger dollar; updates stock price)

14 Oct 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks